Marina Dzhelali

BSc (Hons), Post-Graduate Diploma in Haematology and Haematopoietic Cell transplantation
Research Manager, MRINZ, Wellington, NZ

Marina Dzhelali considers herself a jack of all trades in the medical trial sector. She has worked in clinical research for 25 years, with diverse clinical research experience in oncology, haematology, and paediatrics, along with many other medical fields. 

With a commitment and interest in Good Clinical Practice and compliance, Marina has a strong background in research quality assurance, and currently works as the Associate Director QA, ANZ and Auditor for a HiRO ( a global CRO). She has extensive knowledge and understanding of the techniques, systems and resources that are deployed to give confidence about the care and control with which research is conducted.

She has been also heavily involved in development of the New Zealand Standard Contracts and Indemnity Agreements and other pivotal national research standards. Marina is an Executive Board member of NZ Association for Clinical Research.

---

Pandora’s Box and What Does It Mean For You?

Technology, when implemented with robust control and in compliance regulations, can significantly improve clinical trial process. Digital tools offer powerful enhancements, especially in simplifying information and personalising information but must be integrated thoughtfully, with a continued focus on human connection and regulatory compliance. The future of clinical trials lies in blending digital innovation with ethical, patient-centered practices and strong regulatory frameworks.